Gene therapy knockdown of VEGFR2 in retinal endothelial cells to treat retinopathy.

Authors:
Simmons AB; Bretz CA; Wang H; Kunz E; Hajj K and 5 more

Journal:
Angiogenesis

Publication Year: 2018

DOI:
10.1007/s10456-018-9618-5

PMCID:
PMC6203654

PMID:
29730824

Journal Information

Full Title: Angiogenesis

Abbreviation: Angiogenesis

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Hematology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
1/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:

"The authors would like to thank Gregory Stoddard for his expert advice in biostatistics and Scott Hammond for his help in using microRNA30 embedded shRNAs originally used with the CD44 promoter. This research was supported by the National Eye Institute Grants EY015130, EY017011 (to M.E.H.), and under Ruth L. Kirschstein National Research Service Award EY024234 (to A.B.S.) and by an Unrestricted Grant from Research to Prevent Blindness (to the Department of Ophthalmology & Visual Sciences). Imaging support was provided by the National Eye Institute Vision Core Grant EY014800. T.K. was supported by National Institutes of Health Grants DK058702 and HL128119."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025